Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 930-936-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001-Nov to 2002-Sept
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Similar to OECD 417 test guidelines for radiolabelled toxicokinetic studies but study was limited to evaluating oral bioavailability, radioactivity mass balance andidentifying metabolites in urine; study carried out under GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- Deviations:
- yes
- Remarks:
- limited study to evaluate oral bioavailability and nature of metabolites in urine, one dose conc. only
- Principles of method if other than guideline:
- Study methodology followed general radioactivity toxicokinetic test guidelines for oral absorption, mass balance of radioactivity in urine, feces, cage washes, residual tissues over standard period of 96 hr. Collection of expired air to trap expired radiolabelled carbon dioxide was not carried out since radiolabel is positioned in naphthalene ring. Metabolite profiling of urine was carried out using standard enzymatic (glucuronidase/sulfatase) hydrolysis, extraction, HPLC-radiometric or TLC-radiometric analysis. LC-MS and GC-MS analyses were carried out on urine samples (hyrolyzed, unhydrolyzed and derivatized, i.e., acetylated). The primary purpose of this preliminary toxicokinetic experiment was to provide information on oral bioavailability/absorpiton and on the metabolic disposition of radiolabelled sec-hexadecylnaphthalene in the urine.
- GLP compliance:
- yes
Test material
- Reference substance name:
- Mono-, and di-(sec-hexadecyl)naphthalene
- EC Number:
- 930-936-3
- Molecular formula:
- C26H40 + C42H72
- IUPAC Name:
- Mono-, and di-(sec-hexadecyl)naphthalene
- Details on test material:
- - Name of test material (as cited in study report): MCP 917
- Physical state: liquid
- Radiochemical purity (if radiolabelling): greater than 97% HPLC; 99.8-100% by TLC
- Specific activity (if radiolabelling): 10 millicurie/mmole
- Locations of the label (if radiolabelling): C14-uniformly ring-labelled at 1,4,6,9-positions of naphthalene ring
Source: Moravek Biochemicals, Brea California USA
- Expiration date of radiochemical substance (if radiolabelling): Nov 2006
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- Uniformly ring-labelled C14-sec-hexadecylnaphthalene (MCP 917)
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Duration and frequency of treatment / exposure:
- Male rats were individually dosed with single dose of 100 mg/kg of the unlabelled study substance and the C14-radiolabelled study substance (ca. 7.5 microcurie per animal).
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100 mg/kg unlabelled study substance and C14-radiolabelled study substance in corn oil
Total radiolabel dose was ca 7.5 microcurie per rat.
- No. of animals per sex per dose / concentration:
- 3
- Control animals:
- no
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Based on mass balance analysis , it was estimated that about 10% of the radioactive dose was absorbed orally. The remaining unabsorbed radiolabelled material passed through the GI tract and was recovered in the feces (89% within 48 hr).
- Details on distribution in tissues:
- Only about 2.1% of the radioactivity was found in the residual carcass indicating a low degree of retention or distribution to the tissues at 96 hr. Distribution to individual tissues/organs could not be assessed due to the design of the study (i.e., whole body residual carcass digestion). Individual tissues were not collected and analyzed. Likely organs for distribution would be expected to be liver, kidney, adipose based on diisopropylnaphthalene analog (see Kojima et al. 1978).
- Details on excretion:
- The absorbed radioactivity is primarily excreted in the urine and as conjugated metabolites. Unchanged parent material was not excreted in the urine. HPLC and TLC-radiometric analyses indicated as many as 28 discrete urinary metabolites.
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Metabolites have been identified primarily as glucuronide or sulfate conjugates in the urine. Extensive HPLC and TLC-radimetric analysis of urine samples (hydrolyzed and unhydrolyzed) indicate the presence of about 28 possible metabolites. However, these metabolites have not been fully characterized in spite of extensive LC-MS and GC-MS analyses. The identity of the metabolites have not been fully characterized owing to lack of available synthetic metabolite standards for comparison/confirmation. Metabolism of the hexadecyl group is expected to be major biotransformation pathway in the study substance.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): other: low oral bioavailability and low bioaccumulation potential based on study results
Oral absorption of radiolabelled sec-hexadecylnaphthalene was relatively low, occurring only to the extent of 10% after a single adminstration of 100 mg/kg oral dose in male rats. The study substance was extensively biotransformed to a large number of conjugated metabolites which were excreted in the urine. The metabolites have not been fully characterized but have been demonstrated to be glucuronide or sulfate conjugates, based on enzymatic hydrolysis experiments. - Executive summary:
Radiolabelled sec-hexadecylnaphthalene (100 mg/kg and 7.5 microcurie per animal) was orally adminstered to male rats in a limited toxicokinetic study to evaluate the ADME of the study substance (i.e., primarily to assess oral absorption and metabolism). Oral absorption/ bioavailability was evaluated to be low (10%). Residue carass radioactivity (~2.1%) indicated a low bioaccumulation potential in the tissues. More importantly, the study substance was extensively metabolized to a large number of metabolites (28 discrete components) which were excreted in the urine. The metabolites have not been fully characterized in spite of extensive LC-MS and GC-MS analyses but preliminary data indicate that they are glucuronide or sulfate conjugates. Metabolism of the sec-hexadecyl side-chain group rather than oxidation of the aromatic ring has been proposed as major biotransformation pathway for the study substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.